Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability (Q31660489)

3 July 2017

title

Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability (English)

1 reference

3 July 2017

0 references

1 reference

Jacobsson SO

1

1 reference

3 July 2017

Rongård E

2

1 reference

3 July 2017

Stridh M

3

1 reference

3 July 2017

Tiger G

4

1 reference

3 July 2017

Fowler CJ

5

1 reference

3 July 2017

publication date

1 December 2000

1 reference

3 July 2017

language of work or name

English

0 references

published in

Biochemical Pharmacology

1 reference

3 July 2017

volume

60

1 reference

3 July 2017

issue

12

1 reference

3 July 2017

page(s)

1807-1813

1 reference

Malignant glioma: Should chemotherapy be overthrown by experimental treatments?

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Tamoxifen as a potential treatment of glioma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Enhancement of radiosensitivity by tamoxifen in C6 glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Tamoxifen modulation of carboplatin cytotoxicity in a human U-138 glioma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Tamoxifen inhibits particulate-associated protein kinase C activity, and sensitises cultured human glioblastoma cells not to etoposide but to gamma-radiation and BCNU.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Delta9-tetrahydrocannabinol induces apoptosis in C6 glioma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Lowry protein assay containing sodium dodecyl sulfate in microtiter plates for protein determinations on fractions from brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

An N-terminal Inhibitory Function, IF, Suppresses Transcription by the A-isoform but Not the B-isoform of Human Progesterone Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Developmental expression of calmodulin mRNA and protein in regions of the postnatal rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

The secretion of soluble amyloid beta precursor protein (A beta PPs) by chick neurons in serum-free primary culture is not regulated by protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Estrogen Receptors Are Identified in the Glioblastoma Cell Line UI38MG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Δ9 -Tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

Delta-9-tetrahydrocannabinol interferes with the establishment and the expression of conditioned rejection reactions produced by cyclophosphamide: a rat model of nausea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900492-5

10.1016/S0006-2952(00)00492-5

7 January 2021

Identifiers

DOI

1 reference

3 July 2017

1 reference